K E Osserman, L B Weiner. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Fluorescent Antibody TechniqueHumansMyasthenia Gravis/immunologyPyridostigmine Bromide/therapeutic useThymoma
Substances: See more » Pyridostigmine Bromide
Year: 1965 PMID: 5318080 DOI: 10.1056/NEJM196509162731201
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245